Temasek sees portfolio hit new high, warns of global weakness
Temasek Holdings continued its rapid pace of investment over the past year as the portfolio reached a new record high valuation, but the Singapore investor warned of potential difficulties ahead, noting that the global economy is in a “fragile state.”
After bouncing back sharply from a retraction in 2020, the portfolio continued its ascent, reaching SGD 403bn (USD 297bn) for the 12 months ended March, up from SGD 381bn in 2021. The one-year shareholder...
More on Southeast Asia
Latest News
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.
